Log In
BCIQ
Print this Print this
 

HUEXC030

  Manage Alerts
Collapse Summary General Information
Company Orient Europharma Co. Ltd.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationTuberculosis
Indication DetailsTreat pulmonary tuberculosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today